Published in Immunol Lett on May 01, 1992
Plasmodium falciparum stimuli for human gammadelta T cells are related to phosphorylated antigens of mycobacteria. Infect Immun (1996) 1.25
Naive human alpha beta T cells respond to membrane-associated components of malaria-infected erythrocytes by proliferation and production of interferon-gamma. Immunology (1996) 0.98
Gammadelta+ T cells preferentially respond to live rather than killed malaria parasites. Infect Immun (1998) 0.97
Splenic gammadelta T cells regulated by CD4+ T cells are required to control chronic Plasmodium chabaudi malaria in the B-cell-deficient mouse. Infect Immun (2006) 0.95
The gamma/delta T-cell response to Plasmodium falciparum malaria in a population in which malaria is endemic. Infect Immun (1996) 0.90
Exacerbation of Plasmodium chabaudi malaria in mice by depletion of TCR alpha beta+ T cells, but not TCR gamma delta+ T cells. Immunology (1996) 0.78
A Unique Subset of γδ T Cells Expands and Produces IL-10 in Patients with Naturally Acquired Immunity against Falciparum Malaria. Front Microbiol (2017) 0.75
A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med (1977) 11.49
Infection control in intravenous therapy. Ann Intern Med (1973) 3.59
The case for wider use of testing for HIV infection. N Engl J Med (1989) 2.89
The role of dendritic cells in the initiation of immune responses to contact sensitizers. I. In vivo exposure to antigen. Cell Immunol (1985) 2.43
Passive immunization against murine malaria with an IgG3 monoclonal antibody. J Immunol (1984) 2.40
Immunity to Plasmodium chabaudi adami in the B-cell-deficient mouse. Nature (1981) 2.39
Detection of bacteremia in adults: consequences of culturing an inadequate volume of blood. Ann Intern Med (1993) 2.28
Recognition by human V gamma 9/V delta 2 T cells of a GroEL homolog on Daudi Burkitt's lymphoma cells. Science (1990) 2.25
Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1,497 catheterized patients. Arch Intern Med (2000) 2.19
Freshwater wound infection due to Aeromonas hydrophila. JAMA (1977) 2.16
A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics (2001) 2.10
Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J Immunol (1996) 2.07
Nosocomial urinary tract infection with Serratia marcescens: an epidemiologic study. J Infect Dis (1973) 1.95
Increased gamma delta T cells in acute Plasmodium falciparum malaria. Immunol Lett (1990) 1.87
Bacteriuria in the catheterized patient. What quantitative level of bacteriuria is relevant? N Engl J Med (1984) 1.85
Nosocomial bacteremia. An epidemiologic overview. Am J Med (1981) 1.84
Epidemiology of needle-stick injuries in hospital personnel. Am J Med (1981) 1.83
The effect of cyclophosphamide on the ontogeny of the humoral immune response in chickens. J Immunol (1970) 1.82
Nationwide epidemic of septicemia caused by contaminated intravenous products. I. Epidemiologic and clinical features. Am J Med (1976) 1.81
Nonspecific inhibitor released by T acceptor cells reduces the production of interleukin-2. Nature (1982) 1.75
Reduction of nosocomial infection during pediatric intensive care by protective isolation. N Engl J Med (1989) 1.71
Nonsterilizing immunity in avian malaria: an antibody-independent phenomenon. Proc Soc Exp Biol Med (1976) 1.69
The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med (1991) 1.69
Through a glass darkly. Nosocomial pseudoepidemics and pseudobacteremias. Arch Intern Med (1980) 1.69
Practice guidelines for evaluating new fever in critically ill adult patients. Task Force of the Society of Critical Care Medicine and the Infectious Diseases Society of America. Clin Infect Dis (1998) 1.67
T-cell immunity to malaria in the B-cell deficient mouse. Am J Trop Med Hyg (1979) 1.60
Risk factors for nosocomial infection in intensive care. 'Devices vs nature' and goals for the next decade. Arch Intern Med (1989) 1.59
Adoptive protection against Plasmodium chabaudi adami malaria in athymic nude mice by a cloned T cell line. J Immunol (1988) 1.51
Yes, Virginia, aseptic technique is very important: maximal barrier precautions during insertion reduce the risk of central venous catheter-related bacteremia. Infect Control Hosp Epidemiol (1994) 1.50
Gamma/delta T cell clones and natural killer cell clones mediate distinct patterns of non-major histocompatibility complex-restricted cytolysis. J Exp Med (1990) 1.50
Malarial immunodepression in vitro: adherent spleen cells are functionally defective as accessory cells in the response to horse erythrocytes. Eur J Immunol (1976) 1.47
Nationwide epidemic of septicemia caused by contaminated infusion products. IV. Growth of microbial pathogens in fluids for intravenous infusions. J Infect Dis (1975) 1.43
Inhibition of human immunodeficiency virus replication by nonimmunosuppressive analogs of cyclosporin A. Proc Natl Acad Sci U S A (1995) 1.42
Indirect sandwich enzyme-linked immunosorbent assay for rapid detection of Haemophilus influenzae type b infection. J Clin Microbiol (1979) 1.41
Efficacy of direct Gram stain in differentiating staphylococci from streptococci in blood cultures positive for gram-positive cocci. J Clin Microbiol (1978) 1.40
Duplicate publication of a manuscript. Infect Control Hosp Epidemiol (1990) 1.39
Relation of the inanimate hospital environment to endemic nosocomial infection. N Engl J Med (1982) 1.37
Pathogenesis of SIVmac251 after atraumatic inoculation of the rectal mucosa in rhesus monkeys. J Med Primatol (1993) 1.37
Inhibition of Plasmodium falciparum in vitro by human gamma delta T cells. J Immunol (1994) 1.37
In vitro stimulation with a non-peptidic alkylphosphate expands cells expressing Vgamma2-Jgamma1.2/Vdelta2 T-cell receptors. Immunology (2001) 1.36
Control of colonization and transmission of pathogenic bacteria in the hospital. Ann Intern Med (1978) 1.36
Malaria and alterations in immune reactivity. Br Med Bull (1982) 1.35
A comparative study of polyantibiotic and iodophor ointments in prevention of vascular catheter-related infection. Am J Med (1981) 1.34
The time course of selected malarial infections in cytokine-deficient mice. Exp Parasitol (1997) 1.33
Inactivation of HIV by nonoxynol-9. Lancet (1988) 1.30
Focal vulvitis: a characteristic syndrome and cause of dyspareunia. Features, natural history, and management. Am J Obstet Gynecol (1986) 1.29
Surgical gloves as a mechanical barrier against human immunodeficiency viruses. Br J Surg (1988) 1.28
Use of hydroethidine and flow cytometry to assess the effects of leukocytes on the malarial parasite Plasmodium falciparum. Clin Diagn Lab Immunol (1995) 1.27
Clinical significance of tumor suppressor PTEN in colorectal carcinoma. Eur J Surg Oncol (2010) 1.27
Overwhelming pulmonary blastomycosis associated with the adult respiratory distress syndrome. N Engl J Med (1993) 1.26
A study of antimicrobial misuse in a university hospital. Am J Med Sci (1978) 1.25
The role of T cells in immunity to malaria. Prog Allergy (1988) 1.24
Comparison of hepatitis C viral loads in patients with or without human immunodeficiency virus. Clin Diagn Lab Immunol (2001) 1.24
Guidelines for infection control in intravenous therapy. Ann Intern Med (1973) 1.24
Nationwide epidemic of septicemia caused by contaminated intravenous products: mechanisms of intrinsic contamination. J Clin Microbiol (1975) 1.22
Infection control in total parenteral nutrition. JAMA (1973) 1.21
Susceptibility of CXB recombinant inbred mice to murine plasmodia. Infect Immun (1984) 1.20
Chronic infection with Trypanosoma musculi in congenitally athymic nude mice. Infect Immun (1977) 1.19
Infectious complications in adults with bone marrow transplantation and T-cell depletion of donor marrow. Increased susceptibility to fungal infections. Ann Intern Med (1986) 1.18
A protective monoclonal antibody recognizes a variant-specific epitope in the precursor of the major merozoite surface antigen of the rodent malarial parasite Plasmodium yoelii. J Immunol (1989) 1.17
Splenomegaly, enhanced phagocytosis, and anemia are thymus-dependent responses to malaria. Infect Immun (1978) 1.17
Gamma delta T lymphocyte responses to HIV. Clin Exp Immunol (1996) 1.17
Antibody-independent immunity to reinfection malaria in B-cell-deficient mice. Infect Immun (1983) 1.16
T-cell immunity in murine malaria: adoptive transfer of resistance to Plasmodium chabaudi adami in nude mice with splenic T cells. Infect Immun (1986) 1.16
Functional gamma delta T-lymphocyte defect associated with human immunodeficiency virus infections. Mol Med (1997) 1.16
A prospective study of pathogenesis of catheter-associated urinary tract infections. Mayo Clin Proc (1999) 1.16
Prevention of recrudescent malaria in nude mice by thymic grafting or by treatment with hyperimmune serum. Infect Immun (1977) 1.15
Suppressor cells induced by BCG release non-specific factors in vitro which inhibit DNA synthesis and interleukin-2 production. Immunology (1984) 1.15
Resolution of acute malarial infections by T cell-dependent non-antibody-mediated mechanisms of immunity. Infect Immun (1990) 1.14
Effects of splenectomy on antibody-independent immunity to Plasmodium chabaudi adami malaria. Infect Immun (1985) 1.13
MHC-unrestricted cytotoxic and proliferative responses of two distinct human gamma/delta T cell subsets to Daudi cells. J Immunol (1992) 1.13
Gamma/delta T lymphocytes in viral infections. J Leukoc Biol (1995) 1.12
The resolution of acute malaria in a definitive model of B cell deficiency, the JHD mouse. J Immunol (1994) 1.11
Infections in the neutropenic patient--new views of an old problem. Hematology Am Soc Hematol Educ Program (2001) 1.11
Cytotoxic activities of tanshinones against human carcinoma cell lines. Am J Chin Med (1991) 1.10
Role of CD4+ T cells in the expansion of the CD4-, CD8- gamma delta T cell subset in the spleens of mice during blood-stage malaria. J Immunol (1993) 1.09
Prospective study of replacing administration sets for intravenous therapy at 48- vs 72-hour intervals. 72 hours is safe and cost-effective. JAMA (1987) 1.09
Antigen test versus reverse transcriptase assay for detecting HIV. Lancet (1987) 1.09
Gamma delta T cells function in cell-mediated immunity to acute blood-stage Plasmodium chabaudi adami malaria. J Immunol (1995) 1.08
Immunogenicity and protective efficacy of the WI-1 adhesin of Blastomyces dermatitidis. Infect Immun (1998) 1.06
Antibody-independent mechanisms in the development of acquired immunity to malaria. Adv Exp Med Biol (1983) 1.05
Isolation of retroviruses from two patients with "common variable" hypogammaglobulinaemia. Lancet (1986) 1.04
Surface antimicrobial activity of heparin-bonded and antiseptic-impregnated vascular catheters. J Infect Dis (1993) 1.04
Isolation and bioactivity of new tanshinones. J Nat Prod (1987) 1.04
Reassessment of the role of splenic leukocyte oxidative activity and macrophage activation in expression of immunity to malaria. Infect Immun (1989) 1.04
A semiquantitative culture method for identification of catheter-related infection in the burn patient. J Surg Res (1977) 1.03
Inhibition of HIV replication in vitro by fusidic acid. Lancet (1987) 1.03
Infections caused by aterial catheters used for hemodynamic monitoring. Am J Med (1979) 1.03
Canine infectious cyclic thrombocytopenia found in Taiwan. J Vet Med Sci (1996) 1.03
Human gamma delta T cell subset-proliferative response to malarial antigen in vitro depends on CD4+ T cells or cytokines that signal through components of the IL-2R. J Immunol (1996) 1.02
Management of septic thrombosis of the inferior vena cava caused by Candida. Arch Surg (1978) 1.02
Infections acquired during cardiopulmonary resuscitation: estimating the risk and defining strategies for prevention. Ann Intern Med (1998) 1.02
Cyclophilin a modulates processing of human immunodeficiency virus type 1 p55Gag: mechanism for antiviral effects of cyclosporin A. Virology (1998) 1.02
Induction of apoptosis by garcinol and curcumin through cytochrome c release and activation of caspases in human leukemia HL-60 cells. J Agric Food Chem (2001) 1.01
Safety of changing intravenous delivery systems at longer than 24-hour intervals. Ann Intern Med (1979) 1.01
Heat shock proteins, tumor immunogenicity and antigen presentation: an integrated view. Immunol Today (2000) 1.00